Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis

被引:32
作者
Seo, JS
Lee, SS
Kim, SI
Ryu, WH
Sa, KH
Kim, SU
Han, SW
Nam, EJ
Park, JY
Lee, WK
Kim, SY
Kang, YM
机构
[1] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Junggu 700721, Daegu, South Korea
[2] Pusan Natl Univ, Pusan, South Korea
[3] Chonnam Natl Univ, Kwangju, South Korea
[4] Chonbuk Natl Univ, Chonju, South Korea
[5] Kyungpook Natl Univ, Hlth Promot Res Ctr, Taegu, South Korea
[6] Kyungpook Natl Univ, Sch Med, Dept Orthoped Surg, Taegu, South Korea
关键词
vascular endothelial growth factor; ankylosing spondylitis; polymorphism;
D O I
10.1093/rheumatology/kei013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To investigate the role of polymorphisms of the vascular endothelial growth factor (VEGF) gene in susceptibility to ankylosing spondylitis (AS), and their relationship to clinical features and radiographic severity. Methods. This study included 157 patients with AS and 140 healthy unrelated controls. Polymorphisms of the VEGF gene were analysed by the polymerase chain reaction (PCR)-restriction fragment length polymorphism assay and amplification refractory mutation system-PCR. Haplotypes were reconstructed using the Bayesian algorithm. Radiographic severity was assessed by the Bath Ankylosing Spondylitis Radiological Index (BASRI). Results. The genotype frequencies of the polymorphisms were in Hardy-Weinberg equilibrium. The distributions of genotypes and alleles did not differ between AS patients and controls. Among the six haplotypes reconstructed based on the tight linkage disequilibrium at positions -2578, -1154 and -634 (pairwise linkage disequilibrium coefficient, r = 0.361-0.706), no haplotype was associated with susceptibility to AS. Clinical features were analysed for the four haplotypes (CGC, CGG, AAG, AGG) which were prevalent. In carriers of the AGG haplotype, the frequency of cervical spine involvement was significantly higher (P = 0.002, P-corr = 0.036) and that of patients showing a BASRI score > 6 was also higher (P = 0.025, P-corr = 0.45). Conclusions. This study demonstrates that polymorphisms of the VEGF gene may contribute to disease severity in AS.
引用
收藏
页码:1299 / 1302
页数:4
相关论文
共 50 条
[21]   The effect of transforming growth factor β1 gene polymorphisms in ankylosing spondylitis [J].
Jaakkola, E ;
Crane, AM ;
Laiho, K ;
Herzberg, I ;
Sims, AM ;
Bradbury, L ;
Calin, A ;
Brophy, S ;
Kauppi, M ;
Kaarela, K ;
Wordsworth, BP ;
Tuomilehto, J ;
Brown, MA .
RHEUMATOLOGY, 2004, 43 (01) :32-38
[22]   COMPARISON OF CLINICAL FEATURES IN HLA-B27 POSITIVE AND NEGATIVE PATIENTS WITH ANKYLOSING-SPONDYLITIS [J].
KHAN, MA ;
KUSHNER, I ;
BRAUN, WE .
ARTHRITIS AND RHEUMATISM, 1977, 20 (04) :909-912
[23]   Genetic aspects of ankylosing spondylitis [J].
Khan, MA ;
Ball, EJ .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (04) :675-690
[24]   HLA-B27 HOMOZYGOSITY IN ANKYLOSING-SPONDYLITIS - RELATIONSHIP TO RISK AND SEVERITY [J].
KHAN, MA ;
KUSHNER, I ;
BRAUN, WE ;
ZACHARY, AA ;
STEINBERG, AG .
TISSUE ANTIGENS, 1978, 11 (05) :434-438
[25]   IMMUNOHISTOLOGICAL FEATURES OF SYNOVITIS IN ANKYLOSING-SPONDYLITIS - A COMPARISON WITH RHEUMATOID-ARTHRITIS [J].
KIDD, BL ;
MOORE, K ;
WALTERS, MT ;
SMITH, JL ;
CAWLEY, MID .
ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (02) :92-98
[26]  
Koch AE, 1998, ARTHRITIS RHEUM-US, V41, P951, DOI 10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO
[27]  
2-D
[28]   A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk [J].
Krippl, P ;
Langsenlehner, U ;
Renner, W ;
Yazdani-Biuki, B ;
Wolf, G ;
Wascher, TC ;
Paulweber, B ;
Haass, J ;
Samonigg, H .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) :468-471
[29]   Whole-genome screening in ankylosing spondylitis: Evidence of non-MHC genetic-susceptibility loci [J].
Laval, SH ;
Timms, A ;
Edwards, S ;
Bradbury, L ;
Brophy, S ;
Milicic, A ;
Rubin, L ;
Siminovitch, KA ;
Weeks, DE ;
Calin, A ;
Wordsworth, BP ;
Brown, MA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (04) :918-926
[30]   Vascular endothelial growth factor gene-460 Ce/T polymorphism is a biomarker for prostate cancer [J].
Lin, CC ;
Wu, HC ;
Tsai, FJ ;
Chen, HY ;
Chen, WC .
UROLOGY, 2003, 62 (02) :374-377